Blavatnik Biomedical Accelerator
Pre-Proposal Deadlines: September 13, 2021 for Pilot applications and January 12, 2022 for Development and Pilot applications
Award Amount: $100,000 for 1 year for Pilot grants; $300,000 for 2 years for Development grants

The Blavatnik Biomedical Accelerator at Harvard University provides essential gap funding, development support, and business expertise to help faculty investigators achieve the full potential of their work. The Accelerator seeks to support innovative, investigator-initiated research, and to develop preliminary observations into robust intellectual property positions. Its primary goal is to advance technologies to the point where an industry partnership can commence. Proposals are welcomed from Harvard principal investigators with early-stage research in a range of life science areas, including therapeutics, diagnostics, drug delivery technologies, medical devices/instruments, and enabling technologies for drug discovery. Pilot Grants are intended to support proof-of-concept activities that (if successful) would establish a basis for a subsequent Development Grant proposal. Development Grants are expected to generate partnerable technology within the proposed timeframe.

Harvard Office of Technology Development (OTD) staff will work with applicants to develop a pre-proposal. Only one pre-proposal per applicant will be accepted per cycle. Based on recommendations from the Accelerator Advisory Committee and OTD, a subset of applicants will be invited to submit a full proposal. Questions about this opportunity may be directed to Anu Natarajan (anuradha_natarajan@harvard.edu) or blavatnik_accelerator@harvard.edu.